Abstract
Pregnancy-associated osteoporosis (PAO) is a rare condition of skeletal fragility affecting women in pregnancy or the postpartum period. During normal pregnancy and lactation, substantial changes in calcium metabolism and skeletal physiology occur in order to meet the demands of the developing foetus. Whilst these adaptations are reversible and generally of no clinical consequence for the mother, a small number of women will develop osteoporosis and suffer fragility fractures. Vertebral fractures occur most commonly in PAO and are often multiple. Due to the rarity of PAO, systematic study to date has been limited. Aetiology is poorly understood, but traditional osteoporosis risk factors and genetic factors are likely to play a role. A small number of cases may be due to an underlying metabolic bone disorder or monogenic condition. Management of PAO is challenging, due both to a poor evidence base and the fact that spontaneous improvement in BMD is known to occur once pregnancy and lactation are complete. Bisphosphonates, denosumab and teriparatide have all been used in individual patients, but the data supporting their use are currently limited.
Similar content being viewed by others
References
Kovacs CS, Ralston SH (2015) Presentation and management of osteoporosis presenting in association with pregnancy or lactation. Osteoporos Int 26:2223–2241. https://doi.org/10.1007/s00198-015-3149-3
Kalkwarf HJ (2006) Calcium in pregnancy and lactation. In: Weaver CM, Heaney RP (eds) Calcium in human health. Humana Press, Totowa, pp 297–309
Kovacs C, Kronenberg H (2013) Pregnancy and lactation. In: Rosen C (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism, 8th edn. Wiley-Blackwell, Ames, pp 156–164
Kovacs C (2016) Maternal mineral and bone metabolism during pregnancy, lactation, and post-weaning recovery. Physiol Rev 96:449–547. https://doi.org/10.1152/physrev.00027.2015
Purdie DW, Aaron JE, Selby PL (1988) Bone histology and mineral homeostasis in human pregnancy. BJOG 95:849–54. https://doi.org/10.1111/j.1471-0528.1988.tb06568.x
Naylor KE, Iqbal P, Fledelius C, Fraser RB, Eastell R (2000) The effect of pregnancy on bone density and bone turnover. J Bone Miner Res 15(1):129–137. https://doi.org/10.1359/jbmr.2000.15.1.129
Ettinger AS, Lamadrid-Figueroa H, Mercado-García A, Kordas K, Wood RJ, Peterson KE, Hu H et al (2014) Effect of calcium supplementation on bone resorption in pregnancy and the early postpartum: a randomized controlled trial in Mexican Women. Nutr J 13:116. https://doi.org/10.1186/1475-2891-13-116
Møller UK, Vi Streym S, Mosekilde L, Rejnmark L (2012) Changes in bone mineral density and body composition during pregnancy and postpartum. A controlled cohort study. Osteoporos Int 23:1213–1223. https://doi.org/10.1007/s00198-011-1654-6
Breasail ÓM, Prenticel A, Ward K (2020) Pregnancy-related bone mineral and microarchitecture changes in women aged 30 to 45 years. J Bone Miner Res 35:1253–1262. https://doi.org/10.1002/jbmr.3998
Rizzoli R, Bonjour JP (1997) Hormones and bones. Lancet 349:S20-23. https://doi.org/10.1016/s0140-6736(97)90007-6
Pearson D, Kaur M, San P, Lawon N, Baker P, Hosking D (2004) Recovery of pregnancy mediated bone loss during lactation. Bone 34:570–578. https://doi.org/10.1016/j.bone.2003.11.005
Sowers MF, Corton G, Shapiro B, Jannausch ML, Crutchfield M, Smith ML, Randolph JF et al (1993) Changes in bone density with lactation. JAMA 269:3130–3135. https://doi.org/10.1001/jama.1993.03500240074029
Holmberg-Marttila D, Sievanen H, Laippala P, Tuimala R (2000) Factors underlying changes in bone mineral during postpartum amenorrhea and lactation. Osteoporos Int 11:570–576. https://doi.org/10.1007/s001980070077
Brembeck P, Lorentzon M, Ohlsson C, Winkvist A, Augustin H (2015) Changes in cortical volumetric bone mineral density and thickness, and trabecular thickness in lactating women postpartum. J Clin Endocrinol Metab 100:535–543. https://doi.org/10.1210/jc.2014-2825
Kovacs CS (2017) The skeleton is a storehouse of mineral that is plundered during lactation and (fully?) replenished afterwards. J Bone Miner Res 32:676–680. https://doi.org/10.1002/jbmr.3090
Matsumoto I, Kosha S, Noguchi S-I, Kojima N, Oki T, Douchi T, Nagata Y (1995) Changes of bone mineral density in pregnant and postpartum women. J Obstet Gynaecol (Lahore) 21:419–425. https://doi.org/10.1111/j.1447-0756.1995.tb01031.x
Grizzo FMF, Alarcão ACJ, Dell’ Agnolo CM, Pedroso RB, Santos TS, Vissoci JRN, Pinheiro MM et al (2020) How does women’s bone health recover after lactation? A systematic review and meta-analysis. Osteoporos Int 31:413–427. https://doi.org/10.1007/s00198-019-05236-8
Bjørnerem Å, Ghasem-Zadeh A, Wang X, Bui M, Walker SP, Zebaze R, Seeman E (2017) Irreversible deterioration of cortical and trabecular microstructure associated with breastfeeding. J Bone Miner Res 32:681–687. https://doi.org/10.1002/jbmr.3018
Cooke-Hubley S, Gao Z, Mugford G, Kaiser SM, Goltzman D, Leslie WD, Davison KS et al (2019) Parity and lactation are not associated with incident fragility fractures or radiographic vertebral fractures over 16 years of follow-up: Canadian Multicentre Osteoporosis Study (CaMos). Arch Osteoporosis 14:49. https://doi.org/10.1007/s11657-019-0601-6
Hadji P, Boekhoff J, Hahn M, Hellmeyer L, Hars O, Kyvernitakis I, Grizzo FMF et al (2017) Pregnancy-associated osteoporosis: a case-control study. Osteoporos Int 28:1393–1399. https://doi.org/10.1007/s00198-016-3897-8
Butscheidt S, Delsmann A, Rolvien T, Barvencik F, Al-Bughaili M, Mundlos S, Schinke T et al (2018) Mutational analysis uncovers monogenic bone disorders in women with pregnancy-associated osteoporosis: three novel mutations in LRP5, COL1A1, and COL1A2. Osteoporos Int 29:1643–1651. https://doi.org/10.1007/s00198-018-4499-4
Smith R, Athanasou NA, Ostlere SJ, Vipond SE (1995) Pregnancy-associated osteoporosis. QJM 88:865–878. https://doi.org/10.1093/oxfordjournals.qjmed.a069019
Kovacs CS (2014) Osteoporosis presenting in pregnancy, puerperium, and lactation. Curr Opin Endocrinol Diabetes Obes 21:468–475. https://doi.org/10.1097/MED.0000000000000102
Hardcastle SA, Yahya F, Bhalla AK (2019) Pregnancy-associated osteoporosis: a UK case series and literature review. Osteoporos Int 30(5):939–948. https://doi.org/10.1007/s00198-019-04842-w
Che H, Breuil V, Cortet B, Paccou J, Thomas T, Chapuis L, Debiais F et al (2019) Vertebral fractures cascade: potential causes and risk factors. Osteoporos Int 30:555–563. https://doi.org/10.1007/s00198-018-4793-1
Bonacker J, Janousek M, Kröber M (2014) Pregnancy-associated osteoporosis with eight fractures in the vertebral column treated with kyphoplasty and bracing: a case report. Arch Orthop Trauma Surg 134:173–179. https://doi.org/10.1007/s00402-013-1912-5
Cooper C, Atkinson EJ, MichaelO’Fallon W, Melton JL (1992) Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985–1989. J Bone Miner Res 7(2):221–227. https://doi.org/10.1002/jbmr.5650070214
Kyvernitakis I, Reuter TC, Hellmeyer L, Hars O, Hadji P (2018) Subsequent fracture risk of women with pregnancy and lactation-associated osteoporosis after a median of 6 years of follow-up. Osteoporos Int 29:135–142. https://doi.org/10.1007/s00198-017-4239-1
Jun Jie Z, Ai G, Baojun W, Liang Z (2019) Intertrochanteric fracture in pregnancy- and lactation-associated osteoporosis. J Int Med Res. https://doi.org/10.1177/0300060519858013
Laroche M, Talibart M, Cormier C, Roux C, Guggenbuhl P, Degboe Y (2017) Pregnancy-related fractures: a retrospective study of a French cohort of 52 patients and review of the literature. Osteoporos Int 28:3135–3142. https://doi.org/10.1007/s00198-017-4165-2
Aynaci O, Kerimoglu S, Ozturk C, Saracoglu M (2008) Bilateral non-traumatic acetabular and femoral neck fractures due to pregnancy-associated osteoporosis. Arch Orthop Trauma Surg 128:313–316. https://doi.org/10.1007/s00402-007-0439-z
Breuil V, Brocq O, Euller-Ziegler L (1997) Insufficiency fracture of the sacrum revealing a pregnancy associated osteoporosis. First Case Report Ann Rheum Dis 56:278–279. https://doi.org/10.1136/ard.56.4.278b
Tuna F, Akleylek C, Özdemir H, Demirbağ Kabayel D (2020) Risk factors, fractures, and management of pregnancy-associated osteoporosis: a retrospective study of 14 Turkish patients. Gynecol Endocrinol 36:238–242. https://doi.org/10.1080/09513590.2019.1648417
Cohen A, Kamanda-Kosseh M, Dempster DW, Zhou H, Müller R, Goff E, Colon I et al (2019) Women with pregnancy and lactation-associated osteoporosis (PLO) have low bone remodeling rates at the tissue level. J Bone Miner Res 34:1552–1561. https://doi.org/10.1002/jbmr.3750
O’Sullivan SM, Grey AB, Singh R, Reid IR (2006) Bisphosphonates in pregnancy and lactation-associated osteoporosis. Osteoporos Int 17:1008–1012. https://doi.org/10.1007/s00198-006-0112-3
Hong N, Kim JE, Lee SJ, Kim SH, Rhee Y (2018) Changes in bone mineral density and bone turnover markers during treatment with teriparatide in pregnancy- and lactation- associated osteoporosis. Clin Endocrinol 88:652–665. https://doi.org/10.1111/cen.13557
Patel S (2014) Primary bone marrow oedema syndromes. Rheumatology 53:785–792. https://doi.org/10.1093/rheumatology/ket324
Funk J, Shoback D, Genant H (1995) Transient osteoporosis of the hip in pregnancy: natural history of changes in bone mineral density. Clin Endocrinol 43:373–382. https://doi.org/10.1111/j.1365-2265.1995.tb02046.x
Anai T, Urata K, Mori A, Miyazaki F, Okamoto S (2013) Transient osteoporosis of the hip in pregnancy associated with generalized low bone mineral density-a case report. Gynecol Obstet Invest 76:133–138. https://doi.org/10.1159/000351564
Phillips AJ, Ostlere SJ, Smith R (2000) Pregnancy-associated osteoporosis: Does the skeleton recover? Osteoporos Int 11:449–454. https://doi.org/10.1007/s001980070113
Cerit ET, Cerit M (2020) A case of pregnancy and lactation associated osteoporosis in the third pregnancy; robust response to teriparatide despite delayed administration. Bone Rep 13:100706. https://doi.org/10.1016/j.bonr.2020.100706
Sanchez A, Zanchetta MB, Danilowicz K (2016) Two cases of pregnancy- and lactation-associated osteoporosis successfully treated with denosumab. Clin Cases Miner Bone Metab 13:244–246. https://doi.org/10.11138/ccmbm/2016.13.3.244
Dunne F, Walters B, Marshall T, Heath DA (1993) Pregnancy associated osteoporosis. Clin Endocrinol (Oxf) 39:487–490. https://doi.org/10.1111/j.1365-2265.1993.tb02398.x
Campos-Obando N, Oei L, Hoefsloot LH, Kiewiet RM, Klaver CCW, Simon MEH, Carola Zillikens M (2014) Osteoporotic vertebral fractures during pregnancy: be aware of a potential underlying genetic cause. J Clin Endocrinol Metab 99:1107–1111. https://doi.org/10.1210/jc.2013-3238
Cook FJ, Mumm S, Whyte MP, Wenkert D (2014) Pregnancy-associated osteoporosis with a heterozygous deactivating LDL receptor-related protein 5 (LRP5) mutation and a homozygous methylenetetrahydrofolate reductase (MTHFR) polymorphism. J Bone Miner Res 29:922–928. https://doi.org/10.1002/jbmr.2095
Peris P, Guañabens N, Monegal A, Pons F, Martínez de Osaba MJ, Ros I, Muñoz-Gómez J (2002) Pregnancy associated osteoporosis: the familial effect. Clin Exp Rheumatol 20(5):697–700
Grizzo FMF, da Silva MJ, Pinheiro MM, Jorgetti V, Carvalho MDB, Pelloso SM (2015) Pregnancy and lactation-associated osteoporosis: bone histomorphometric analysis and response to treatment with zoledronic acid. Calcif Tissue Int 97:421–425. https://doi.org/10.1007/s00223-015-0028-z
Bayram S, Ozturk C, Sivrioglu K, Aydinli U, Kucukoglu S (2006) Kyphoplasty for pregnancy-associated osteoporotic vertebral fractures. Jt Bone Spine 73:564–566. https://doi.org/10.1016/j.jbspin.2005.11.015
Li LJ, Zhang J, Gao P, Lv F, Song YW, Chang XY, Zhao DC et al (2018) Clinical characteristics and bisphosphonates treatment of rare pregnancy- and lactation-associated osteoporosis. Clin Rheumatol 37:3141–3150. https://doi.org/10.1007/s10067-018-4185-0
Hellmeyer L, Kühnert M, Ziller V, Schmidt S, Hadji P (2007) The use of i. v. bisphosphonate in pregnancy-associated osteoporosis—case study. Exp Clin Endocrinol Diabetes 115:139–142. https://doi.org/10.1055/s-2007-967091
Naylor KE, Bradburn M, Paggiosi MA, Gossiel F, Peel NFA, McCloskey EV, Walsh JS et al (2018) Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density. Osteoporos Int 29:1407–1417. https://doi.org/10.1007/s00198-018-4460-6
Ioannis SP, Chrysoula LG, Aikaterini K, George T, George LP, Nikolaos PA, Symeon T et al (2011) The use of bisphosphonates in women prior to or during pregnancy and lactation. Hormones 10:280–291. https://doi.org/10.14310/horm.2002.1319
Ornoy A, Wajnberg R, Diav-Citrin O (2006) The outcome of pregnancy following pre-pregnancy or early pregnancy alendronate treatment. Reprod Toxicol 22:578–579. https://doi.org/10.1016/j.reprotox.2006.05.009
Levy S, Fayez I, Taguchi N, Han JY, Aiello J, Matsui D, Moretti M et al (2009) Pregnancy outcome following in utero exposure to bisphosphonates. Bone 44:428–430. https://doi.org/10.1016/j.bone.2008.11.001
Vujasinovic-Stupar N, Pejnovic N, Markovic L, Zlatanovic M (2012) Pregnancy-associated spinal osteoporosis treated with bisphosphonates: Long-term follow-up of maternal and infants outcome. Rheumatol Int 32:819–823. https://doi.org/10.1007/s00296-011-1816-z
Ijuin A, Yoshikata H, Asano R, Tsuburai T, Kikuchi R, Sakakibara H (2017) Teriparatide and denosumab treatment for pregnancy and lactation-associated osteoporosis with multiple vertebral fractures: a case study. Taiwan J Obstet Gynecol 56:863–866. https://doi.org/10.1016/j.tjog.2017.10.028
Stumpf UC, Kurth AA, Windolf J, Fassbender WJ (2007) Pregnancy-associated osteoporosis: an underestimated and underdiagnosed severe disease. A review of two cases in short- and long-term follow-up. Adv Med Sci 52:94–97
Choe EY, Song JE, Park KH, Seok H, Lee EJ, Lim SK, Rhee Y (2012) Effect of teriparatide on pregnancy and lactation-associated osteoporosis with multiple vertebral fractures. J Bone Miner Metab 30(5):596–601. https://doi.org/10.1007/s00774-011-0334-0
Hellmeyer L, Boekhoff J, Hadji P (2010) Treatment with teriparatide in a patient with pregnancy-associated osteoporosis. Gynecol Endocrinol 26:725–728. https://doi.org/10.3109/09513591003649831
Lee SH, Hong M-K, Park SW, Park H-M, Kim J, Ahn J (2013) A case of teriparatide on pregnancy-induced osteoporosis. J Bone Metab. 20(2):111–114. https://doi.org/10.11005/jbm.2013.20.2.111
Nasto LA, Pambianco V, Autore G, Colangelo D, Pontecorvi A, Pola E (2017) Multiple vertebral fractures in three young women with acute postpartum osteoporosis: Description and treatment. Glob Spine J 7(2):P287. https://doi.org/10.1177/2192568217708189
Pola E, Colangelo D, Nasto LA, Pambianco V, Autore G, Formica VM, Maccauro G (2016) Pregnancy-associated osteoporosis (pao) with multiple vertebral fragility fractures: diagnosis and treatment in a young primigravid woman. J Biol Regul Homeost Agents 30(4 Suppl 1):153–158
Lampropoulou-Adamidou K, Trovas G, Stathopoulos IP, Papaioannou NA (2012) Case report: teriparatide treatment in a case of severe pregnancy-and lactation- associated osteoporosis. Hormones 11:495–500. https://doi.org/10.14310/horm.2002.1383
Cohen A, Kamanda-Kosseh M, Recker RR, Lappe JM, Dempster DW, Zhou H, Cremers S et al (2015) Bone density after teriparatide discontinuation in premenopausal idiopathic osteoporosis. J Clin Endocrinol Metab 100(11):4208–4214. https://doi.org/10.1210/jc.2015-2829
Tanriover MD, Oz SG, Sozen T, Kilicarslan A, Guven GS (2009) Pregnancy- and lactation-associated osteoporosis with severe vertebral deformities: can strontium ranelate be a new alternative for the treatment? Spine J 9:e20–e24. https://doi.org/10.1016/j.spinee.2008.06.451
Tanriover MD, Oz SG, Sozen T (2015) Ten-year follow-up in pregnancy and lactation-associated osteoporosis: sequential therapy with strontium ranelate and ibandronate. Spine J 15(5):1164–1165. https://doi.org/10.1016/j.spinee.2014.10.022
Zarattini G, Buffoli P, Isabelli G, Marchese M (2014) Pregnancy-associated osteoporosis with seven vertebral compression fractures, a case treated with strontium ranelate. Clin Cases Miner Bone Metab 11:139–141. https://doi.org/10.11138/ccmbm/2014.11.2.139
Ebeling PR, Akesson K, Bauer DC, Buchbinder R, Eastell R, Fink HA, Giangregorio L et al (2019) The efficacy and safety of vertebral augmentation: a second ASBMR task force report. J Bone Miner Res 34(1):3–21. https://doi.org/10.1002/jbmr.3653
Acknowledgements
SH is grateful to Dr Ashok Bhalla for his helpful comments on the manuscript.
Author information
Authors and Affiliations
Contributions
SH is the sole author of this work and assumes responsibility for the entire manuscript.
Corresponding author
Ethics declarations
Conflict of interest
SH received conference fee funding from Lilly (UK) in 2018.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hardcastle, S.A. “Pregnancy and Lactation Associated Osteoporosis”. Calcif Tissue Int 110, 531–545 (2022). https://doi.org/10.1007/s00223-021-00815-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-021-00815-6